Genetic abnormalities predisposing to autoimmunity generally act in a cooperative manner affecting one or several mechanisms regulating immunological tolerance. In addition, many of these genetic abnormalities are also involved in the development of lymphoproliferative diseases. In the present study, we have determined 
Introduction
With rare exceptions, the development of autoimmune diseases requires the contribution of multiple genetic, epigenetic and environmental factors. These factors generally act in a cooperative manner affecting one or several mechanisms that regulate the induction and maintenance of immunological tolerance [1] . Among the best characterized genetic alterations involved in the development of autoimmunity, are those that affect the regulation of lymphocyte survival. Using a line of transgenic (Tg) mice overexpressing human Bcl-2 (hBcl-2) in B lymphocytes, we and others have demonstrated that Tg mice bearing a pro-autoimmune genetic background develop a lethal autoimmune lupus-like syndrome that is dependent on the activity of CD4 + lymphocytes [2, 3] . However, the overexpression of hBcl-2 in B cells from C57BL/6 (B6) mice, which do not have a genetic predisposition to developing the disease, fails to promote autoimmune manifestations [2] , indicating that the inhibition of B lymphocyte apoptosis by itself is not sufficient to trigger a severe autoimmune reaction. Similarly, B6 mice deficient in bim or Fas fail to develop a fatal autoimmune pathology in contrast to the severe systemic lupus erythematosus (SLE) observed in mixed (129/Sv x B6)-bim −/− or MRL.Fas lpr mice, respectively [4] [5] [6] .
The deregulation in the control of lymphocyte proliferation is also associated with the development of autoimmune diseases. In this sense, mice deficient in p21 WAF1/Cip1 (p21; a member of the Cip/Kip family of cell cycle inhibitors) in a line of mice with a mixed (129/Sv x B6) genetic background (derived from 2-3 intercrosses) develop a fatal lupus-like syndrome that affects females more than males [7] . Similarly, the administration of a peptidyl mimic of p21 into (NZB x NZW)F 1 females significantly reduces the severity of the spontaneous SLE in these animals [8] . Again, the severity of the autoimmune syndrome in p21 -/-mice appears to be modulated by the genetic background of the mice analyzed. Thus, B6 and BXSB mice deficient in p21 or an additional line of p21 -/-mixed (129/Sv x B6) mice, derived from an unknown number of intercrosses, are largely protected from the development of SLE [9] [10] [11] [12] . Another member of the Cip/Kip family acting as a negative regulator of cell cycle is p27 kip1 (p27). Studies have shown that p27 plays an important role in the induction and maintenance of clonal anergy of T lymphocytes induced after inhibition of costimulation [13] . In anergic CD4 + T lymphocytes, p27 inhibits the phosphorylation of Smad-3 resulting in an increase of the inhibitor of Cdks, p15. Consequently, the deficiency in p27 prevents the induction of clonal anergy in T lymphocytes [14] .
However, p27 -/-mice do not develop evident autoimmune manifestations [15] .
In addition to their ability to promote autoimmunity in the context of a particular genetic predisposition, the cell cycle and apoptotic regulators mentioned above may be also involved in tumor development. In this regard, Bcl-2 was initially identified as a gene implicated in the t(14:18) chromosomal translocation found in the majority of follicular B-cell lymphomas [16] and Tg mice overexpressing Bcl-2 in B cells spontaneously developed plasmacytomas or immunoblastic B-cell lymphomas albeit with a low incidence [17, 18] . Similarly, an association between Burkitt's lymphomas and mutations in p21 that diminish the functional activity of this cell cycle regulator has been reported in humans [19] , and p21 On the other hand, the deficiency in p27 failed to promote autoimmune responses in B6.hBcl-2-B Tg mice, indicating the existence of preferential interactions among particular regulators of the G 1 /S transition of the cell cycle and cell survival for the control of B-cell tolerance. Laboratories, Inc., West Grove, PA), at concentrations of 20 g/ml. Cell division was analyzed by flow cytometry according to the CFSE intensity dilution.
Materials and methods

Mice
Flow cytometry studies
The number of total B220, B220 
Serological studies
Serum levels of total IgA and IgG were determined by ELISA as described previously [2, 25] . Results were expressed in mg/ml in reference to a standard curve obtained with a mouse reference serum (ICN Biomedicals Inc.). The presence of IgG and IgA anti-DNA autoAbs was determined in sera by ELISA as described [2, 25] and the results expressed in TU in reference to a standard curve obtained from a serum pool from 6-8 months old MRL lpr/lpr mice. Serum levels of IgG gp70 anti-gp70 immune complexes (gp70 IC) were quantified by ELISA [26] and the results expressed as g of Ab-bound gp70/ml of serum.
Histopathology
Samples of all major organs were obtained at autopsy. Organs were included in paraffin and stained with hematoxilin-eosin or Masson trichrome for pathological studies. Glomerulonephritis was scored on a 0 to 4 scale as previously described [27] . 
Statistical analysis
Statistical analysis of differences between groups of mice was performed using the Mann-Whitney test. Probability values <0.05 were considered significant.
Results
Lack of the effect of p21 deficiency on the survival and proliferation of B cells overexpressing hBcl-2
We first determined whether p21 deficiency modulated the anti-apoptotic activity of hBcl-2 in B cells from B6.p21 Table   1 ). In correlation with the production of autoAb and the expansion of B200 (Table 2 ). In contrast, the respective incidences were 19% and 2% in B6.p21
-/-mice, and 0% and 17% in B6.hBcl-2-B Tg mice.
Discussion
The control of cell cycle and survival is essential for the maintenance of lymphoid homeostasis and self-tolerance. Disruption in the regulation of any of these processes in mice can lead to autoimmunity and/or LPD [1] . However, the development of pathology in these animals, particularly autoimmune diseases, is largely influenced [10] [11] [12] , suggesting the existence of unknown strain-specific genetic interactions that modulate the accelerator activity of this genetic abnormality in autoimmunity.
There are multiple evidences indicating that p27 is an important regulator of clonal anergy of T lymphocytes [13, 14] . In this sense, p27 is required for transplantation tolerance induced by costimulatory blockade [31] . However, p27 abnormalities that prolong B cell survival (at least Bcl-2 overexpression). In this hierarchy, the pro-autoimmune potential of p21deficiency in cooperation with B-cell hBcl-2 overexpression is higher than that of E2F1 or E2F2 deficiency, which in turn is superior to that of p27 deficiency.
In addition to its anti-apoptotic activity, Bcl-2 is also involved in the control of cellular proliferation. In particular, the overexpression of Bcl-2 in lymphocytes or fibroblasts significantly delays the cell cycle entry of these cells after activation [29, 30] . On the other hand, p21 may act as a survival factor in several cell types, including T lymphocytes [28] . Consistent with a previous finding [7] , our B6.p21 mice/group are expressed as the mean ± SD of the number of cells of each population. 
